Welcome to our dedicated page for Cross Ctry Healthcare SEC filings (Ticker: CCRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cross Country Healthcare, Inc. (CCRN) SEC filings page on Stock Titan provides centralized access to the company’s public filings with the U.S. Securities and Exchange Commission. As a Nasdaq-listed issuer, Cross Country Healthcare submits a range of documents that detail its financial condition, governance, and material corporate events.
Investors can use this page to locate current and historical reports such as annual reports on Form 10‑K and quarterly updates on Form 10‑Q, which the company references in its proxy materials and earnings communications. These reports typically include audited or reviewed financial statements, segment information for Nurse and Allied Staffing and Physician Staffing, discussions of Homecare and Education staffing activities, and management’s analysis of operational efficiency, technology investments, and market conditions.
The filings page also surfaces current reports on Form 8‑K, which Cross Country Healthcare uses to disclose significant events. Recent examples include 8‑Ks reporting quarterly financial results furnished under Item 2.02, updates on the Agreement and Plan of Merger with Aya Healthcare and its termination, the automatic extension of the merger agreement end date, the scheduling of the 2025 Annual Meeting of Stockholders, and the CEO transition in which co‑founder and Chairman Kevin C. Clark was appointed President and Chief Executive Officer.
In addition, users can review the company’s definitive proxy statements on Schedule 14A, which describe board composition, director qualifications, executive compensation, and key proposals submitted to stockholders. These documents also summarize strategic priorities such as strengthening the operational foundation, advancing technology capabilities, and addressing workforce needs across healthcare, homecare, and education markets.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, helping readers quickly understand the implications of new 10‑K, 10‑Q, 8‑K, and proxy filings. Real-time updates from EDGAR, combined with simplified explanations of complex disclosures, make it easier to track Cross Country Healthcare’s regulatory reporting and governance developments, including items related to potential transactions, capital allocation, and leadership changes.
CROSS COUNTRY HEALTHCARE INC Group President, Delivery Marc S. Krug reported equity compensation activity involving the company’s common stock. He received a grant of 21,024 restricted shares that vest in three substantially equal installments on March 31, 2027, March 31, 2028 and March 31, 2029.
On the same date, 1,123 shares and 1,339 shares were withheld at a price of $9.40 per share to cover tax withholding obligations for restricted stock that vested on March 31, 2026. After these transactions, Krug directly owns 77,232 common shares.
CROSS COUNTRY HEALTHCARE INC Chief Operating Officer Amiee Lin Hawkins reported routine equity compensation and related tax withholding in company stock. She received a grant of 15,958 restricted shares of common stock, which vest in three substantially equal installments on March 31, 2027, March 31, 2028 and March 31, 2029. To cover tax obligations on restricted stock that vested on March 31, 2026, a total of 1,278 shares were withheld at a price of $9.40 per share through two transactions. After these transactions, she directly holds 43,953 shares of common stock.
Clark Kevin Cronin reported acquisition or exercise transactions in this Form 4 filing.
Cross Country Healthcare Chief Executive Officer Kevin Cronin reported an award of 138,963 shares of restricted common stock at no purchase price. These shares vest in three substantially equal installments on March 31, 2027, March 31, 2028 and March 31, 2029.
Following the award, he holds 948,133 shares directly. A separate line reflects 3,961 shares held indirectly by his spouse, for which he disclaims beneficial ownership except for any pecuniary interest.
CROSS COUNTRY HEALTHCARE INC Chief Financial Officer William J. Burns reported routine equity compensation and related tax withholding transactions in company stock. He received a grant of 47,873 restricted shares of common stock at no cost, which vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
To cover tax obligations on restricted stock that vested on March 31, 2026, 2,423 shares and 2,890 shares of common stock were withheld at a value of $9.40 per share. After these transactions, Burns directly holds 336,438 shares of CROSS COUNTRY HEALTHCARE INC common stock.
Cross Country Healthcare General Counsel Susan E. Ball reported routine equity compensation and related tax withholding transactions. On March 31, 2026, she received a grant of 33,644 shares of common stock at no cost, described as restricted shares that will vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029.
On the same date, 1,689 and 2,014 shares were withheld at $9.40 per share to satisfy tax withholding obligations for restricted stock that vested on March 31, 2026. After these transactions, she directly holds 241,777 shares of Cross Country Healthcare common stock.
CROSS COUNTRY HEALTHCARE INC Chief Accounting Officer Marvin Veizaga reported equity compensation activity in company stock. He received a grant of 9,043 shares of common stock, described as restricted shares that vest in three substantially equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. To cover tax withholding obligations for restricted stock that vested on March 31, 2026, 938 shares were withheld in two transactions at $9.40 per share. After these transactions and a correction for 4,471 previously omitted shares from an earlier Form 3, Veizaga directly holds 31,716 shares of common stock.
Cross Country Healthcare is asking stockholders to vote at its virtual 2026 Annual Meeting on May 11, 2026, including electing six directors, ratifying Deloitte & Touche as auditor, approving 2025 executive pay on an advisory basis, and amending the 2024 Omnibus Incentive Plan.
CEO Kevin Clark has returned with a mandate to restore growth after a terminated merger with Aya Healthcare that slowed 2025 momentum. The company highlights a debt‑free balance sheet and 2025 revenue of about $1.1 billion, Adjusted EBITDA of $26.8 million (2.5% margin), Adjusted EPS of $0.02, strong cash flow of $48.3 million, and repurchases of 0.8 million shares for $6.5 million.
The six‑member board is majority independent, with robust committee oversight of audit, compensation, governance, cybersecurity, environmental and climate risks, and artificial intelligence. Executive pay is heavily performance‑based; 2025 cash incentives paid out well below target and no performance shares were earned for the 2023–2025 cycle, while new 2025 equity awards were granted late in the year with multi‑year vesting and performance goals tied to cumulative Adjusted EBITDA and Adjusted EPS.
Cross Country Healthcare, Inc. reported that its Board of Directors appointed Amiee Hawkins as Chief Operating Officer, effective March 28, 2026. She previously served as Chief Solutions and Operations Officer and has held a series of senior operational roles since joining the company in 2014.
The company stated there were no new or amended agreements or changes to Ms. Hawkins’ compensation in connection with this appointment. It also disclosed that she has no family relationships with directors or executive officers and no material related-party transactions requiring disclosure.